All Categories
Hybrid Work Strategies: 3 Tips to Transform Engagement
 | In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a focus on employee well-being. Changes in supply chain, clinical trials, and regulatory dynamics have accentuated all of this. The changing landscape presents both challenges and opportunities for all of us in biopharma as we look… Read the full article… |
Medical Affairs: An Orchestra, Not a Horse Race
 | Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar. But the metaphor only goes so far — launch preparation is not simply about speed, and in this case, the “horses” keep changing, and the… Read the full article… |
Three Big Mistakes
 | Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic commercialization plans of many more. While no two launches are ever exactly the same — based on the team, company, and unmet need the drug hopes to address — there… Read the full article… |
What’s the Latest?
 | There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your path was into biopharma (I was headed toward academic medicine with my MD/PhD but diverted for the reasons described below), or it could be the diverse companies where… Read the full article… |
Gen Z Advice for Seasoned Boomers
 | “Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how the breakfast conversation began earlier this month between my Gen Z son and his boomer parents. To put this in context, you need to know that it was yet another rainy holiday… Read the full article… |
Find Your Own Light
 | It’s no secret that the last few years have been hard on just about everyone. COVID, climate change, political strife in the US and around the world… the list is long and troubling. Closer to home, biopharma has experienced its own set of challenges. As a recent article in The Boston Globe described, our industry is… Read the full article… |
The Truth about Teams
 | When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are often two very different things. Not for lack of trying (in most cases!), the practical constraints of time, resources, and human nature often get in the way. Fortunately, there are approaches to… Read the full article… |
Running the Biopharma Marathon
 | When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for a district sales manager role. Boston, let alone the Marathon, just wasn’t part of my world. All that changed when I moved to Newton, to a… Read the full article… |
Rare Diseases: Shaping Biopharma’s Future from the Past
 | We just completed Rare Disease month. With that in mind, Sue has asked me to step in for today’s e-conversation, as this topic is very much a part of my focus and professional experience. A few weeks ago, I conducted a virtual discussion with an esteemed panel of seasoned executives and former Genzyme veterans: Jim Geraghty, Masako… Read the full article… |
“Rare Disease” Is More Than Just a Day
 | “It is important for all of us to appreciate where we come from and how that history has really shaped us in ways that we might not understand.” Justice Sotomayor You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However, this insight has stuck with me… Read the full article… |